Targeting AMP‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. HCC treatment is hindered by the frequent emergence of chemoresistance to the multikinase inhibitor sorafenib, which has been related to the presence of cancer stem cells (CSCs) that self‐renew and often escape ther...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Oncol
Asıl Yazarlar: Bort, Alicia, Sánchez, Belén G., Mateos‐Gómez, Pedro A., Vara‐Ciruelos, Diana, Rodríguez‐Henche, Nieves, Díaz‐Laviada, Inés
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2019
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487713/
https://ncbi.nlm.nih.gov/pubmed/30959553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12488
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller